Skip to main content
HR 2025 115th Congress House Health Administrative law and regulatory procedures Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug, alcohol, tobacco use

Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017

Introduced: April 6, 2017 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 6, 2017
Referred to the House Committee on Energy and Commerce.
Apr 6, 2017
Introduced in House
 Plain-English summary Congressional Research Service

Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to prevent an application for a new drug from being considered ineligible for approval because its labeling includes information describing abuse-deterrent properties that otherwise would be blocked by market exclusivity provisions.

The Department of Health and Human Services shall issue draft guidance and publish final guidance regarding the award and scope of exclusivity for new drugs with properties designed to deter abuse and the exceptions to such exclusivity.

The bill applies to applications and supplements to applications that are submitted or pending approval on or after January 1, 2017.

What's happening now April 7, 2017

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2